Characterisation of the Sek-1 receptor tyrosine kinase  by Becker, Nathalie et al.
FEBS 15724 FEBS Letters 368 (1995) 353-357 
Characterisation of the Sek-1 receptor tyrosine kinase 
Nathalie Becker a'*, Pascale Gilardi-Hebenstreit b, Tania Seitanidou a, David Wilkinson c, 
Patrick Charnay a 
aUnitk INSERM 368, Biologie Molkculaire du Ddveloppement, Ecole Normale Supbrieure, 46 rue d'Ulm, 75230 Paris' Cedex 05, France 
bUnitb INSERM 412, Virologie Humaine, Ecole Normale Sup&ieure Lyon, 46 allde d'Italie, 69364 Lyon Cedex 07, France 
CMRC Laboratory of Developmental Neurobiology, National Institute for Medical Research, The Ridgeway, Mill Hill, London N W7 1AA, UK 
Received 31 May 1995 
Abstract We present an initial characterisation of the mouse 
Sek-1 protein, a member of the Eph subfamily of putative recep- 
tor tyrosine kinases, which has been proposed to play a role in 
the segmentation"of both the hindbrain and the mesoderm. Anti- 
bodies raised against the protein have been used to confirm the 
early embryonic expression pattern previously established by 
mRNA in situ hybridisation. These antibodies, together with the 
expression of the Sek-1 gene in a baculovirus ystem, were instru- 
mental in demonstrating that the protein carries a tyrosine kinase 
activity and that it is presented at the cell surface with its N- 
terminal (putative ligand-binding) domain outside of the cell. 
Therefore, as expected from its amino acid sequence, Sek-1 con- 
forms to the general model of receptor-type tyrosine kinases. 
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transduction pathways and their biological functions are 
largely unknown, although an interaction between one member 
(Eck) and phosphatidylinositol-3 kinase has recently been re- 
ported [32], and Eck's ligand (B61) has been shown to be in- 
volved in angiogenesis [33]. 
In this study, we present an inital characterisation f the 
Sek-1 protein. We have raised antibodies against Sek-1 and 
demonstrate hat they reveal a pattern in whole mount mouse 
embryos consistent with previous mRNA in situ hybridisation 
studies. We have used these antibodies in conjunction with the 
production of Sek-1 in a baculovirus expression system to 
analyse the subcellular localisation of the protein and to dem- 
onstrate that it is phosphorylated ontyrosines in vivo, and that 
in vitro it has the capacity for autophosphorylation on tyrosine 
residues. 
2. Materials and methods 
1. Introduction 
Receptor-tyrosine kinases (RTKs) are transmembrane pro- 
teins mediating the transduction of signals required for the 
control of various and essential developmental processes, uch 
as cell growth, differenciation and migration [1]. In all cases 
analysed so far, ligand binding leads to RTK dimerisation and 
activation of the cytoplasmic tyrosine kinase catalytic domain 
resulting in receptor autophosphorylation at specific tyrosine 
residues [2]. Subsequently, phosphorylated receptors associate 
with a specific repertoire of cytoplasmic kinase substrate pro- 
teins that belong to different signalling pathways [3]. 
The recently discovered Eph family has rapidly grown to 
represent the largest RTK subfamily [4,5]. Its members are 
characterised bya specific type of putative xtracellular domain 
which includes a series of 19 conserved cysteine residues and 
two fibronectin type III repeats. The catalytic intracellular do- 
main and the C-terminal extremity are also highly conserved 
among the different members. The presence of the fibronectin 
type III motifs, which are observed in several adhesion mole- 
cules [6,7], raises the possibility that Eph family members might 
be involved in cell-cell or cell-matrix interactions in addition 
to their possible role in signal transduction. However, the bio- 
chemical and functional characterisation f the Eph family has 
so far been limited. Despite the analysis of the developmental 
expression pattern of a few members [5,8-21] and the recent 
cloning of genes encoding candidate ligands [22-31], the mode 
of action of these proteins, the elements of their downstream 
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2.1. Production of antibodies and immunohistochemistry 
The Sek-11 antibody, directed against the intracellular part of Sek-1, 
was obtained by injection of a peptide corresponding to the 11 C- 
terminal amino-acids ofSek-1 coupled to Keyhole-Limpet hemocyanin 
(KLh). For generation ofantibodies directed against the extracellular 
part of Sek-1 (Sek-1E), an MS2-polymerase fusion protein including the 
N-terminal part of Sek-1 (nucleotide positions 258 to 879) was pro- 
duced in bacteria. Rabbits were injected every three weeks with 10 ,ug 
of KLh-peptide (6 injections), or 50/~g of the MS2-polymerase-Sek-I 
fusion protein (5 injections). Immuno-histochemistry on whole mount 
embryos was performed as described [34]. The anti-Sek antibodies and 
the peroxidase-conjugated goat anti-rabbit antibody (Sigma) were 
added at 10000- and 200-fold ilutions, respectively. The peroxydase 
revelation was performed using 2,5 g/1 4-chloro-l-naphtol in a 40% 
ethanol solution containing 0,006% v/v H202. 
2.2. Expression of Sek-1 using the baculovirus ystem 
A Sek-1 cDNA fragment (nucleotide positions 57 to 3198) was sub- 
cloned into the pBluebac vector (Invitrogen). The resulting plasmid was 
cotransfected with a wild-type baculovirus toproduce aSek-I recombi- 
nant baculovirus, which was selected by a revelation offl-galactosidase 
activity and hybridisation with a Sek-1 cDNA probe. Spodoptera frugi- 
perda (Sf9) cells (kindly provided by Lucien Cabani6) were cultured in 
TC-100 medium (Gibco), supplemented with 10% fetal bovine serum 
(Techgen), 100 u/ml penicillin, 100 mg/1 streptomycin, 100 mg/l 
kanamycin and 2 mM glutamine (Gibco). Infections were performed 
on plates as described [35]. 
2.3. Immunofluorescence and confocal microscopy 
48 hours after infection, cells were preiucubated in PBS, 0,5% BSA; 
Sek-11 or Sek-1E antibodies were added at a 7500-fold ilution, for 1.5 
hours. Following 2 × 5 minutes washes in the preincubation solution, 
a FITC-conjugated anti-rabbit antibody (Biosys) was added at a 300- 
fold dilution and incubated for one hour. After two additional PBS 
washes and fixation on cover slides coated with poly-L-lysine (Sigma) 
in a 1:1 methanol/acetone solution at 4°C, slides were covered and 
examined with a confocal microscope as described [36]. 
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Fig. 1. Schematic representation f the eDNA clones used for the reconstruction f a full-length cDNA sequence of Sek-1, and of the regions encoding 
the different domains of the protein. The regions of the protein used to raise the Sek-1E and Sek-11 antibodies are indicated underneath. Restriction 
sites and nucleotide positions are indicated in italics. S.S, signal sequence; T.M., transmembrane domain. 
2.4. Immunoblotting, immunoprecipitation and kinase assay 
Proteins were fractionated by electrophoresis on 7,5% poly- 
acrylamide gels. Quantification was carried out by Coomassie blue 
staining and comparison with fl-galactosidase used as a marker. Frac- 
tionated proteins were transferred onto nitrocellulose filters (Schleicher 
and Schtill), and immunodetection was performed using a chemilumi- 
nescence kit (Boehringer) as recommended bythe manufacturer. Rab- 
bit polyclonal anti-Sek-1 and mouse monoclonal nti-phospho-tyrosine 
(Sigma) antibodies were used at 7500- and 2000-fold ilutions respec- 
tively. Peroxidase-conjugated s condary antibodies were used at 10000- 
and 2000-fold dilutions for the anti-rabbit (Bio-Rad) and the anti-mouse 
(Institut Pasteur) antibodies, respectively. Immunoprecipitations were 
performed with the Sek- 1I antibody conjugated toProtein-A Sepharose 
beads (Pharmacia) as recommended bythe manufacturer. Cell extracts 
and kinase assays were performed as described [37]. 
3. Results 
3.1. Reconstruction of the complete Sek-1 coding sequence and 
generation of specific antibodies 
A eDNA covering the complete coding sequence of the Sek-1 
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Fig. 2. Characterisation f the antibodies directed against Sek-1. (A) Whole mount immunodetection of the Sek-1 protein with the Sek-11 antibody. 
Dorsal view of a 9.5 dpc mouse embryo, showing Sek-I in rhombomeres 3 (r3) and 5 (r5) and in the otic vesicle (or). (B) Western blot detection 
of Sek-I from baculovirus infected insect cells. For each lane approximatively 104 Sf9 cells were lysed in sample buffer, deposited on a 7.5% 
polyacrylamide g l and analysed by western blotting using either the Sek-1 I, Sek-1E or pre-immune (PI) seras. NI, non-infected cells; WT, wild-type 
baculovirus infected cells; Sek-l, Sek-1 baculovirus infected cells. 
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Fig. 3. Sek-1 incorporation i to the cell membrane. Cells infected with the Sek-I baculovirus were incubated at 4°C with Sek-lI (A) or Sek-lE (B) 
antibodies, processed for immunodetection with a fluorescence- conjugated second antibody, and observed in confocal microscopy. Labelling is 
observed only with Sek-lE, directed against the putative xtracellular domain. A linear colour scale (0-255) is shown. 
gene was obtained by ligation of four previously isolated frag- 
ments [9] (Fig. 1). The Sek-1 cDNA encodes a protein with a 
predicted unmodified molecular mass of 107279 Da [9]. Consis- 
tently, in vitro translation of Sek-1 mRNA derived from the 
cDNA clone generated a 110 kDa protein (data not shown). 
Rabbit polyclonal antibodies were generated against a pep- 
tide consisting of the 11 carboxy-terminal amino acids and a 
bacterial fusion protein, including a large part of the putative 
extracellular domain. They were named Sek-lI and Sek-lE 
respectively. Their specificity was analysed by immunohisto- 
chemistry on whole mount 9.5 day post-coitum embryos. In 
both cases labelling of rhombomeres 3 and 5, of the otic vesicle, 
and of the prospective somites, was observed (Fig. 2A and data 
not shown). This is consistent with the previously reported 
mRNA pattern [9,10]. No labelling was observed with pre- 
immune sera (data not shown). These data demonstrate he 
specificity of the Sek-lE and Sek-lI antisera. 
3.2. Characterisation of the Sek-1 protein produced in a 
baculovirus expression system 
To analyse the cellular localisation of the Sek-1 protein, as 
well as its possible kinase activity, we used a baculovirus expres- 
sion system to produce large amounts of protein, with presum- 
ably bona fide post-translational modifications [38]. A recombi- 
nant baculovirus, containing the coding sequence of Sek-1 
under the control of the viral polyhedrin promoter, was con- 
structed. Western blotting analysis of extracts from cells in- 
fected with the Sek-1 recombinant baculovirus led to the detec- 
tion of a 120 kDa protein with both Sek-lE and Sek-11 antibod- 
ies (Fig. 2B). The 120 kDa protein was not observed with 
non-infected cells or cells infected by a wild-type virus, nor was 
it detected with pre-immune sera (Fig. 2B). The amount of 
Sek-1 protein produced was estimated to about one microgram 
per 2 × 10 5 Sf9 cells (data not shown)• The antibodies were 
subsequently used to study the cellular localisation of Sek-1 by 
immunofluorescence analysis of infected cells. Sf9 cells infected 
with the recombinant Sek-1 baculovirus produced very large 
amounts of Sek-1 protein, most of which accumulated within 
the cytoplasm (data not shown). To demonstrate hat receptor 
molecules were expressed at the cell surface, infected cells were 
incubated with Sek- 1E or Sek- 11 antibodies without permeabil- 
isation. As expected, no staining was observed with the Sek-lI 
antibody (Fig. 3A). In contrast, strong surface labelling was 
observed with Sek-lE antibody (Fig. 3B). These data demon- 
strate that at least part of the Sek-1 molecules present in Sf9 
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Fig. 4. Sek-1 is phosphorylated ontyrosine residues in vivo. Extracts 
from approximatively 5 × 104 Sf9 infected cells were immunoprecipi- 
rated with the Sek-lI antibody and subjected toWestern blot analysis. 
Lanes 1 and 5 correspond to extracts prepared from wild type bacu- 
lovirus infected cells, while the other samples were obtained from Sek-1 
recombinant baculovirus infected cells. In lanes 2 and 6, the im- 
munoprecipitation was performed inpresence ofa competitor peptide 
(0.2 mg/ml) while in the other lanes no competitor was included. In 
lanes 4 and 8, the immunoprecipitation wasperformed with the preim- 
mune antibody. The Western blot was revealed with an anti-phosphoty- 
rosine antibody in the lanes 1 to 4. The same blot was subsequently 
stripped and incubated with the Sek-lE antibody (lanes 5 to 8). The 
positions of migration of molecular mass markers (in kDa) are indicated. 
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Fig. 5. Autophosphorylation of Sek-1 on tyrosine residues. (A) In vitro 
phosphorylation f Sek-l. Extracts from approximatively 5 x 10 4 Sf9 
infected cells were immunoprecipitated with the Sek-11 antibody, incu- 
bated with [?'-3ZP]ATE separated by electrophoresis on a 7.5% poly- 
aerylamide gel and revealed by autoradiography. Lane 1 corresponds 
to extracts prepared from wild type baculovirus infected cells, while the 
other lanes are obtained from Sek-1 recombinant baculovirus infected 
cells. In lane 3, the immunoprecipitation wasperformed inpresence of
a competitor peptide (0.2 mg/ml) which was omitted in the other lanes. 
In lane 4, the immunoprecipitation wasperformed with the preimmune 
sera. (B) Western blot analysis of autophosphorylated S k-1 with anti- 
phosphotyrosine antibodies. Extracts from Sf9 cells infected with the 
Sek-1 recombinant baculovirus (except for lanes 1 and 4, in which case 
the cells were infected with wild-type virus) were immunoprecipitated 
with the Sek- 11 antibody. They were subsequently incubated with (lanes 
1, 3, 4 and 6) or without (lanes 2 and 5) [y-32p]ATP, separated by 
electrophoresis on a 7.5% polyaerylamide geland blotted. In the upper 
part of the figure, the filters were analysed with either anti-phosphoty- 
rosine (lanes 1 to 3) or Sek-IE (lanes 4 to 6) antibodies. In the lower 
part, the same filters were exposed for autoradiography (two days). 
Habitually, the equivalent ofapproximatively 2 x 105 cells was depos- 
ited per lane, except for lanes 2 and 5 where approximatively 106 cells 
were used. The positions of migration of molecular mass markers (in 
kDa) are indicated. 
cells are incorporated into the cytoplasmic membrane with the 
expected orientation, i.e. with the N-terminal domain exposed 
outside. 
3.3. Sek-1 is phosphorylated on tyrosine residues in SJ9 cells 
The phosphorylation status of Sek-1 synthetised in SO cells 
was analysed in the following way. Extracts from infected cells 
were submitted to an immunoprecipitation with the Sek-11 an- 
tibody, followed by an analysis by Western blotting. The blots 
were first revealed with an anti-phosphotyrosine antibody. 
After stripping, the blots were reprobed with the Sek-lE anti- 
body. Both antibodies led to the detection of a single band, 
corresponding to the same mobility (Fig. 4). The corresponding 
protein was not detected from wild-type virus infected cell ex- 
tracts. These data demonstrate hat at least part of the Sek-1 
molecules in Sf9 cells are phosphorylated ontyrosine residues. 
3.4. Sek-1 auto-phosphorylation tyrosine residues in vitro 
Although the tyrosine phosphorylation f Sek-1 indicates its 
correct post-translational modification in the baculovirus ex- 
pression system, it does not however demonstrate the phospho- 
rylation activity of the protein. To investigate such an activity, 
we performed a kinase assay on immunoprecipitated Sek-1 
molecules. We found that incubation of the Sek-1 immunopre- 
cipitate with [y-32p]ATP led to labeling of the protein (Fig. 5A), 
suggesting that autophosphorylation indeed occurs. To demon- 
strate that this autophosphorylation involves tyrosine residues, 
the immunoprecipitated protein was subjected to the kinase 
assay in presence or in absence of ATP (Fig. 5B, lower part) 
and analysed by Western blotting using the anti-phosphoty- 
rosine antibody. The phosphotyrosine signal was approxima- 
tively 5 times more intense in the presence of ATP, relative to 
the amount of Sek-1 deposited (Fig. 5B, upper part). Sek-lE 
antibody was used to confirm that the tyrosine-phosphorylated 
and [y-32p]ATP-labelled protein corresponded to Sek-1. To- 
gether, these data demonstrate that the Sek-1 protein can mod- 
ulate autophosphorylation on tyrosine residues. 
4.  D iscuss ion  
The characterisation f the Sek-1 protein presented in this 
paper relied on the generation of two specific antibodies, di- 
rected against he N- and C-terminal domains, and on the 
production of Sek-1 proteins in a baculovirus expression sys- 
tem. The antibodies allowed us to demonstrate hat the distri- 
bution of the protein in 9.5 day post-coitum ouse mbryos is 
consistent with the previously described mRNA pattern. The 
immuno-localisation of Sek-1 in insect cells expressing the 
mouse protein established that it is anchored at the cellular 
membrane, with its C-terminal domain inside the cell and its 
N-terminal domain outside. Finally, we showed that Sek-1 pre- 
pared from these cells is phosphorylated on tyrosine residues 
and that it has the capacity to autophosphorylate on tyrosine 
residues in vitro. Consistent with our data, the putative chick 
ortholog of Sek-1, Cek-8, is recognised by antibodies directed 
against phosphotyrosine residues [39]. 
These results upport he hypothesis, based on the examina- 
tion of the Sek-1 amino acid sequence [9], that this molecule 
might constitute a membrane-bound receptor protein tyrosine 
kinase. They suggest that Sek-1 conforms to the general model 
for receptor tyrosine kinases which implies the presentation f 
the putative ligand binding domain at the external surface of 
the cell and the presence of the catalytic domain inside. Fur- 
thermore, the Sek-1 tyrosine autophosphorylation activity is 
consistent with receptor autophosphorylation f llowing dimer- 
isation induced by ligand binding [2] or fixation of antibodies. 
The fact that some of the Sek-1 molecules are found 
phosphorylated ontyrosine residues in insect cells, although we 
do not know whether this involves the same residue(s) auto- 
phosphorylated in vitro , might be due to the presence of a 
ligand in the serum used for cell culture or to the very high 
concentration f the protein at the membrane [40]. Recently, 
a membrane-bound protein with affinity for the N-terminal 
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domain of Sek-1 was identified [24]. It therefore constitutes a 
putative ligand, although the relatively low measured affinity 
makes the physiological significance of this observation ques- 
tionable. In any case, taken together these data establish that 
Sek-1 indeed encodes a receptor-type tyrosine kinase which 
may play a role in signal transduction mechanisms involved in 
particular in central nervous system patterning during early 
development. 
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